Form 8-K - Current report:
SEC Accession No. 0001193125-25-139959
Filing Date
2025-06-12
Accepted
2025-06-12 16:27:55
Documents
12
Period of Report
2025-06-10
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d949783d8k.htm   iXBRL 8-K 24355
  Complete submission text file 0001193125-25-139959.txt   137498

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrca-20250610.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20250610_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20250610_pre.xml EX-101.PRE 11262
14 EXTRACTED XBRL INSTANCE DOCUMENT d949783d8k_htm.xml XML 3618
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 251043137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)